2019 China Pharmaceutical New Intelligence Forum Officially Launched with Four Key Highlights Announced

On November 7, the “2019 China Pharmaceutical New Intelligence Forum,” themed “Riding the Waves of Innovation, Harnessing Collective Wisdom,” was officially launched in Nanchang during the “14th China Growth-Oriented Pharmaceutical Enterprise Development Forum.” The event was guided by the China Medical Pharmaceutical Materials Association and hosted by Sina Pharmaceutical News and the (China) Food and Drug Industry Think Tank. More than ten launching guests and 6,000 pharmaceutical professionals jointly witnessed this significant moment.

Launch Guests:

Former Deputy Director of the State Food and Drug AdministrationZhang Wenzhou

Deputy Director of the Department of News and Publicity, former State Food and Drug AdministrationShen Chen

Former President of China Pharmaceutical News AgencyFang Xianye

Former Deputy Director of the Southern Institute for Pharmaceutical Economics, National Medical Products AdministrationTao Jianhong

President of the Committee on Chinese Medicinal Materials and Decoction Pieces, China Medical Pharmaceutical Material Association; Former Vice President of Nanjing University of Chinese MedicineCai Baochang

Vice President of the China Pharmaceutical Commercial AssociationWu Bin

Vice President of the China Medical Supplies Association, President of the Chain Pharmacy BranchXu Yuping

Vice President of the China Medical Pharmaceutical Material Association, President of the Growth Pharmacy BranchLi Yuedong

Vice President of the China Medical Pharmaceutical Materials Association, Chairman of Shandong Sibangde Pharmaceutical Trading Co., Ltd.Yuan Wujie

Vice President of the China Medical Pharmaceutical Materials AssociationZhou Li

Deputy Secretary-General of the Think Tank, China Medical Pharmaceutical Materials AssociationPan Shan

General Manager, Sina Medical News OperationsLiu Tao

At the launch ceremony, Pan Shan, Deputy Secretary-General of the Think Tank of the China Pharmaceutical Material Association, officially unveiled the forum’sFour Core Highlights: “High-Level Dialogue on the Future of China’s Pharmaceutical and Healthcare Industry Development,” “Release and Interpretation of the High-Quality Development Index for China’s Pharmaceutical Industry,” “Release of the Sina Medicine + JD Health E-Commerce Development Index for Internet-Based Pharmaceutical and Healthcare Services,” and “New Wisdom Hub · 2019 Annual Value Pioneer List for the Pharmaceutical Industry”, aiming to deeply analyze the variables and future of China's "Internet + Healthcare" industry, while exploring the next "golden decade" of high-quality development for China's pharmaceutical and health industry.

The “2019 China Pharmaceutical New Intelligence Forum” will be held in Beijing on December 27, 2019. At this special juncture, as we bid farewell to 2019 and step into 2020, we are delighted to observe that China’s pharmaceutical and health industry is demonstrating its vitality, courage, and vision to the world. An increasing number of innovative Chinese drugs are emerging and embarking on a journey toward “global novelty”; more and more pharmaceutical retail enterprises are moving toward intensification and specialization amid the trend of capitalization; meanwhile, the unstoppable wave of the internet is bringing profound impacts and transformations to the pharmaceutical industry, ranging from empowerment to disruption.

At this pivotal juncture, as the trillion-yuan new health economy market is poised for full-scale expansion and the next decade dawns, how can China’s pharmaceutical and health industry achieve high-quality development? To address this question, the forum has invited the most authoritative policy experts and leading practitioners to engage in dialogue, directly confronting the industry’s true pain points and challenges. (Major guests to be announced soon—stay tuned…)

Led by VBInsight, the think tank of China’s food and drug industry, this is the first index focused on the high-quality development of the pharmaceutical sector, offering a panoramic scan and professional assessment of China’s pharmaceutical industry. The analytical standards and model of the China Pharmaceutical High-Quality Development Index aim to provide a solid theoretical basis and practical guidance for innovation and development in the pharmaceutical industry. By dissecting the industrial landscape and development direction under new circumstances, the index ensures that new technologies play a positive role in enhancing drug quality, credit-based regulation, and other key areas.

“High-Quality Development Index of China’s Pharmaceutical Industry” Indicator System encompasses influencing factors across all stages of the drug lifecycle, including drug registration and manufacturing, sales, marketing, and distribution. It also incorporates dimensions such as regulatory compliance, brand equity, and corporate social responsibility, comprising five primary indicators and 22 secondary indicators.

For the first time, two Chinese internet giants have joined forces to analyze the pharmaceutical and healthcare industry, leveraging a rich and comprehensive content ecosystem along with vast user profiles from pharmaceutical e-commerce platforms to provide an in-depth analysis of the myriad new opportunities in the “Internet + Healthcare” market.

Since 2016, Sina Medicine has successfully held three annual general ranking awards. This year marks the first collaboration with the China Pharmaceutical Material Association, hosting a grand award ceremony at the New Wisdom Forum.

“New Intelligence Hub · 2019 Annual Value Pioneer List for the Pharmaceutical Industry” is a rigorously curated ranking that integrates professional scrutiny with quantitative data assessment. As a prestigious industry selection event, it adheres to the principles of objectivity, fairness, and transparency. By evaluating individuals, enterprises, products, and projects through quantitative data indicators, expert panels, and online voting, the list aims to identify true explorers and practitioners who create value, sustain innovative vitality, and exert a positive influence on industrial transformation.

Here, we cordially invite all distinguished guests and corporate representatives to attend and participate in the evaluation. Together, let us navigate market competition and shape a new landscape for the industry in the next decade.

Date: December 27, 2019

Location: Beijing, China

Guided by: China Pharmaceutical Material Association

Organizers: Sina Pharmaceutical News, (China) Food and Drug Industry Think Tank

Organizers: Yidu Media, Linghang Consulting

Consultation Hotline: 010-61934050-818

Registration Method: Scan the QR code below to access the registration page.

Scan the QR code below to access the conference registration portal directly.